Investing.com -- Barclays downgraded DexCom and Insulet, two large-cap diabetes device makers, to Underweight as it expects rising competition in 2026 and 2027 to weigh on valuation multiples and ...
While still a couple of years out, MD+DI gained some insights into Dexcom's next-generation sensor from an interview with the ...
In his inaugural J.P. Morgan Healthcare Conference speech, newly minted Dexcom CEO Jake Leach looked to ease concerns over ...
ZME Science on MSN
This Glowing Skin Patch Acts Like a “Check Engine” Light for Your Body to Warn You About Health Problems
Your body could get its own check engine light with this new glowing skin technology from Japan When you are driving and a ...
In July, Leach was tapped to take the CEO role permanently at the start of 2026 as part of Dexcom’s planned succession ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback